MiRNAs are categorised as small non-coding RNA molecules that play a key role in the diagnosis and treatment of many diseases, including those of neurological origin.
Recent scientific studies show that miRNA-16 may help in the treatment of Alzheimer's disease. This is because it inhibits the expression of APP and FNABE1 and, importantly, prevents the production of beta-amyloid. It has also been shown to be an inhibitor of Tau protein phosphorylation. It is against these proteins that treatments for Alzheimer's disease are sought. Research on miRNA-16 is currently being conducted on animal material. These are very promising. It may be possible to use this molecule to treat patients in the future.